Category: Intl’ Pharmaceuticals

Intl' Pharmaceuticals

Aerogen Collaborating on COVID-19 Therapeutics

Aerogen has released details of a broad collaborative effort to support pharmaceutical companies...

Positive Data for Merck’s Pneumococcal Conjugate Vaccine Candidate
AstraZeneca Halts Phase 3 Study of COVID-19 Vaccine after Illness
AstraZeneca’s COVID-19 Vaccine Candidate Begins Phase 3 Trial
FDA Approves Generic Albuterol Sulfate
Cystic Fibrosis Drug Kaftrio Will Become Available on NHS
Russia COVID-19 Vaccine Reportedly Tested on Just 76 Humans
COVID-19 Vaccine Candidate Protected Upper, Lower Airways in Primate Study

Intl' Pharmaceuticals

Unclear Results for Gilead’s Remdesivir for Severe Covid-19

The first clinical results for remdesivir's effectiveness on severe COVID-19 demonstrated clinical improvements but remain unclear because no control group was included in the study.

Fluzone High-Dose Quadrivalent Approved for Adults 65+
Canada’s OHIP to Cover Cystic Fibrosis Drug Kalydeco

Category: Intl’ Pharmaceuticals

Intl' Pharmaceuticals

Aerogen Collaborating on COVID-19 Therapeutics

Positive Data for Merck’s Pneumococcal Conjugate Vaccine Candidate

AstraZeneca Halts Phase 3 Study of COVID-19 Vaccine after Illness

AstraZeneca’s COVID-19 Vaccine Candidate Begins Phase 3 Trial

FDA Approves Generic Albuterol Sulfate

Cystic Fibrosis Drug Kaftrio Will Become Available on NHS

Russia COVID-19 Vaccine Reportedly Tested on Just 76 Humans

COVID-19 Vaccine Candidate Protected Upper, Lower Airways in Primate Study

Intl' Pharmaceuticals

Unclear Results for Gilead’s Remdesivir for Severe Covid-19

Fluzone High-Dose Quadrivalent Approved for Adults 65+

Canada’s OHIP to Cover Cystic Fibrosis Drug Kalydeco

Intl' Pharmaceuticals

Sorry, No Posts Found

Sorry, No Posts Found